Document is current

Article History

Received: 20 March 2020

Accepted: 11 May 2020

First Online: 24 May 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Marcello Casaccia Bertoluci: has received grants and fees from Astra-Zeneca, Novo Nordisk, Boehringer Ingelheim, Sanofi, and Amgen.João Eduardo Nunes Salles: has received speaker’s fees and sat on boards for Abbott Nutrition, Abbott ADC, AstraZeneca, Bayer, Boeringher Ingelheim, Eli Lilly, Merck Serono, MSD, and Novo Nordisk.José Silva-Nunes: has received research support or honoraria for consultancy or training activities from Abbott, AstraZeneca, Bial, Boehringer Ingelheim, Eli Lilly & Company, Janssen Pharmaceuticals, Medinfar, Merck SA, Merck Sharp & Dohme, Mundipharma, Novartis Pharmaceuticals, Novo Nordisk, Roche, Sanofi, Servier, and Tecnimede.Hermelinda Cordeiro Pedrosa: sits on an advisory board for Roche and has received support for participation in scientific conferences from AstraZeneca, Novo Nordisk, and Servier.Rodrigo Oliveira Moreira: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Merck Serono, Servier, Takeda, Libbs, Sanofi-Aventis.Rui Manuel Calado da Silva Duarte: has received research grants and/or honoraria as a consultant, member of advisory board(s), or speaker from Abbott, AstraZeneca, Boehringer Ingelheim, Lilly, Medinfar, MSD, Novartis, Novo-Nordisk, Tecnimede, and Sanofi.Davide Mauricio da Costa Carvalho: has sat on advisory boards and is speaker for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Mundipharma, Novo Nordisk, Novartis, and Sanofi.Fábio Rogério Trujilho: has received speaker’s fees from AstraZeneca, Boehringer-Lilly, Eurofarma, NovoNordisk, Sanofi, Servier, and Takeda.João Filipe Cancela dos Santos Raposo: has received speaker’s fees from or sat on advisory boards for Novo Nordisk, AstraZeneca, Eli Lilly, Abbott, and Boehringer Ingelheim.Erika Bezerra Parente: has received speaker’s fees from Sanofi, Abbott, and Eli Lilly; sits on the advisory board of Sanofi.Fernando Valente: NovoNordisk, AstraZeneca.Fábio Ferreira de Moura: has received speaker’s fees and/or support for participation in scientific conferences from Novo Nordisk, AstraZeneca, and Boehringer Ingelheim.Alexandre Hohl: has served as a scientific consultant for AstraZeneca, Novo Nordisk, and Sanofi.Miguel Melo: has consulting relationships with Bial and has participated in advisory panels and presented lectures for: Abbott, AstraZeneca, Bial, Boehringer Ingelheim, Johnson & Johnson, Lilly, NovoNordisk, Sanofi.Francisco Garcia Pestana Araujo: has received speaker’s fees from and/or served as an investigator in trials sponsored by Astra, Lilly, Medinfar, MSD, Tecninfar.Rosa Maria Monteiro Castro de Araújo Principe: has served as a clinical investigator in trials sponsored by Novo Nordisk, Bayer, and Sanofi.Adriana Costa e Forti: has received clinical research grants and/or support for participation in scientific conferences from AstraZeneca, Boehringer, Lilly, MSD, Novo Nordisk, Sanofi, Takeda.Cynthia Melissa Valerio: has received clinical research grants, speaker’s fees, and/or support for participation in scientific conferences from Novo Nordisk, Takeda, and Novartis.João Manuel Sequeira Duarte: has received grants and fees as consultant, speaker and investigator in clinical trials from Sanofi, Lilly, AstraZeneca, Novo Nordisk, Boehringer Ingelheim, Mundipharma, MSD, Tecnimed, and Bial.Melanie Rodacki: has received event sponsorship and speaker’s fees from Novo Nordisk, Abbott, and Sanofi.Pedro Manuel Patricio de Matos: has sat on advisory boards for MSD and AstraZeneca, and has received honoraria and research support from MSD, AstraZeneca, Boehringer-Lilly, Novo Nordisk, Abbott, and Bayer AG.Pedro Carneiro de Melo Pereira de Magalhães: has served as principal investigator in clinical trials sponsored by Bayer Pharma AG and Novo Nordisk; sits on advisory or expert boards for AstraZeneca; and has received support for participation in scientific conferences from Bial, Medinfar, Novo Nordisk, Sanofi.Rosângela Roginski Réa: has received clinical research grants, speaker’s fees, and/or support for participation in scientific conferences from AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Janssen, Merck, MSD, Novo Nordisk, Sanofi, and Takeda.Roberto Tadeu Barcellos Betti, Patrícia Quadros Branco, Rosane Kupfer, Thaisa Dourado Guedes Trujilho, Maria Helane Costa Gurgel Castelo, Cristiane Bauermann Leitão, Hélder José Ferreira, José Francisco Kerr Saraiva, Mariana Pereira Monteiro, Lana Catani Ferreira Pinto declare no conflicts of interest.